Edgestream Partners L.P. purchased a new stake in shares of Proto Labs, Inc. (NYSE:PRLB – Free Report) in the 3rd quarter, Holdings Channel reports. The fund purchased 35,035 shares of the industrial products company’s stock, valued at approximately $3,323,000.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. BlackRock Inc. bought a new stake in Proto Labs during the 2nd quarter valued at approximately $317,581,000. American Capital Management Inc. purchased a new stake in shares of Proto Labs in the second quarter valued at $50,524,000. Renaissance Technologies LLC boosted its position in shares of Proto Labs by 5.4% during the first quarter. Renaissance Technologies LLC now owns 520,251 shares of the industrial products company’s stock valued at $29,665,000 after buying an additional 26,700 shares during the period. Arrowstreet Capital Limited Partnership grew its position in Proto Labs by 0.7% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 463,780 shares of the industrial products company’s stock valued at $26,445,000 after acquiring an additional 3,162 shares during the last quarter. Finally, S Squared Technology LLC bought a new stake in Proto Labs during the 2nd quarter valued at about $23,484,661. 84.54% of the stock is owned by hedge funds and other institutional investors.
Proto Labs Price Performance
Proto Labs stock opened at $62.90 on Friday. The company has a market cap of $1.50 billion, a PE ratio of 43.99 and a beta of 1.52. The stock’s 50 day moving average price is $82.66 and its 200 day moving average price is $73.98. Proto Labs, Inc. has a 1-year low of $46.70 and a 1-year high of $99.96.
Proto Labs (NYSE:PRLB – Get Free Report) last released its quarterly earnings results on Thursday, October 29th. The industrial products company reported $0.63 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.60 by $0.03. Proto Labs had a net margin of 6.04% and a return on equity of 5.40%. The company had revenue of $154.32 million for the quarter, compared to analysts’ expectations of $149.31 million. During the same period last year, the company earned $0.47 EPS. The firm’s revenue for the quarter was up 13.7% compared to the same quarter last year. On average, equities research analysts anticipate that Proto Labs, Inc. will post 1.52 EPS for the current fiscal year.
Analyst Ratings Changes
A number of research analysts have recently issued reports on the company. Zacks Research downgraded Proto Labs from a “strong-buy” rating to a “hold” rating in a report on Friday, October 2nd. William Blair reiterated a “market perform” rating on shares of Proto Labs in a research note on Monday, November 2nd. Needham & Company LLC upped their price target on Proto Labs from $87.00 to $110.00 and gave the stock a “buy” rating in a report on Friday, October 23rd. Weiss Ratings upgraded Proto Labs from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating on shares of Proto Labs in a report on Tuesday, October 27th. Four analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $100.50.
Read Our Latest Stock Report on PRLB
Insider Buying and Selling at Proto Labs
In related news, CFO Daniel Schumacher sold 5,000 shares of the business’s stock in a transaction that occurred on Thursday, September 24th. The stock was sold at an average price of $95.32, for a total transaction of $476,600.00. Following the sale, the chief financial officer owned 35,019 shares of the company’s stock, valued at $3,338,011.08. The trade was a 12.49% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Suresh Krishna bought 750 shares of the company’s stock in a transaction dated Monday, November 2nd. The stock was purchased at an average cost of $69.52 per share, for a total transaction of $52,140.00. Following the completion of the transaction, the chief executive officer owned 30,897 shares of the company’s stock, valued at $2,147,959.44. This represents a 2.49% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have sold 10,000 shares of company stock valued at $902,629 in the last quarter. Corporate insiders own 1.30% of the company’s stock.
Proto Labs Company Profile
Proto Labs, Inc. is a digital manufacturing company that helps businesses make custom parts for product development and production. Its services connect customers with manufacturing capabilities through an online platform, supporting projects from prototypes to production runs. The company offers injection molding, computer numerical control (CNC) machining, 3D printing and sheet metal fabrication. Customers can submit designs online for review and receive quotes and feedback intended to help them assess and refine parts before manufacturing.
Recommended Stories
- Five stocks we like better than Proto Labs
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Want to see what other hedge funds are holding PRLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Proto Labs, Inc. (NYSE:PRLB – Free Report).
Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.
